AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Aptiv, you need to believe its software and perception stack can become a larger earnings engine than its cyclical auto hardware base, even as margins remain under pressure. The Robust.AI win reinforces Aptiv’s push into higher-value, non-automotive AI and robotics, but it does not change the near term focus on stabilizing profitability, or the key risk that slower auto production, China volatility, and weaker margins could keep earnings and the share price under strain.
Among recent announcements, the expansion of Aptiv’s collaboration with NVIDIA around production-ready edge AI is especially relevant to the Robust.AI news. Together, these updates show Aptiv trying to build an ecosystem around its PULSE perception and compute platforms, which could help it participate in ADAS and industrial robotics opportunities while partially offsetting risks tied to auto volumes, project roll-offs, and slower EV adoption.
Yet alongside these advances in AI and robotics, investors should be aware that...
Read the full narrative on Aptiv (it's free!)
Aptiv's narrative projects $14.6 billion revenue and $1.6 billion earnings by 2029.
Uncover how Aptiv's forecasts yield a $78.21 fair value, a 32% upside to its current price.
While PULSE wins hint at upside, the most pessimistic analysts still see Aptiv revenue falling to about US$13.6 billion and needing higher margins, so you should weigh that against the risk of OEM insourcing key electronics and software.
Explore 2 other fair value estimates on Aptiv - why the stock might be worth just $78.21!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com